Literature DB >> 7882339

Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells.

S Kimura1, T Maekawa, K Hirakawa, A Murakami, T Abe.   

Abstract

This study was designed using c-myc antisense oligodeoxynucleoside phosphorothioate (AS PS-ODN) to evaluate how alterations of c-myc expression in HL-60 human myeloid leukemia cells could influence the induction of apoptosis. Unexpectedly both the continuous down-regulation of c-myc expression caused by exposure to c-myc AS PS-ODN and up-regulation after its withdrawal influenced apoptosis. We found that continuous suppression of c-myc expression by 10 microM c-myc AS PS-ODN could decrease the proliferation of HL-60 cells to approximately 60% of the control growth after 3 days of suspension culture, and when assessed morphologically the percentage of cells undergoing apoptosis was 3.5%. Evidence either of cell cycle arrest or cell cycle prolongation was not detected. It is likely that apoptosis induced by the sustained down-regulation of c-myc expression with AS PS-ODN treatment was solely sufficient to explain the inhibition of cell proliferation. Up-regulation of c-myc expression was observed within 1 h after c-myc AS PS-ODN withdrawal. This up-regulation further enhanced induction of apoptosis and involved up to 32% of the cells. These results suggest that while the continuous suppression of c-myc expression caused a constant effect on the induction of apoptosis, its abrupt up-regulation could rapidly drive a considerable number of HL-60 cells into the apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882339

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb.

Authors:  I J Moon; Y Lee; C S Kwak; J H Lee; K Choi; A D Schreiber; J G Park
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  A new cell line from human undifferentiated carcinoma of the ovary: establishment and characterization.

Authors:  J W Kim; C G Lee; M S Lyu; H K Kim; J G Rha; D H Kim; S J Kim; S E Namkoong
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

4.  Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells.

Authors:  Sivalokanathan Sarveswaran; Ritisha Ghosh; Rujul Parikh; Jagadananda Ghosh
Journal:  Mol Cancer Ther       Date:  2016-07-29       Impact factor: 6.261

5.  Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.

Authors:  S Gryaznov; T Skorski; C Cucco; M Nieborowska-Skorska; C Y Chiu; D Lloyd; J K Chen; M Koziolkiewicz; B Calabretta
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

6.  Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer.

Authors:  Masaki Nogawa; Takeshi Yuasa; Shinya Kimura; Motoyoshi Tanaka; Junya Kuroda; Kiyoshi Sato; Asumi Yokota; Hidekazu Segawa; Yoshinobu Toda; Susumu Kageyama; Tatsuhiro Yoshiki; Yusaku Okada; Taira Maekawa
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

7.  A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide.

Authors:  Hua Fan-Minogue; Sandhya Bodapati; David Solow-Cordero; Alice Fan; Ramasamy Paulmurugan; Tarik F Massoud; Dean W Felsher; Sanjiv S Gambhir
Journal:  Mol Cancer Ther       Date:  2013-07-03       Impact factor: 6.261

8.  Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.

Authors:  Sivalokanathan Sarveswaran; Debrup Chakraborty; Dhananjay Chitale; Rosalie Sears; Jagadananda Ghosh
Journal:  J Biol Chem       Date:  2014-12-24       Impact factor: 5.157

9.  Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.

Authors:  X Jiang; J Li; M Paskind; P M Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate.

Authors:  Y Huang; R Snyder; M Kligshteyn; E Wickstrom
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.